Misleading results from immunoassays of serum free thyroxine in the presence of rheumatoid factor

Clinical Chemistry

Volumn 43, Issue 6, 1997, Pages 957-962

  Norden, Anthony G W ^a   Jackson, Rodwin A ^b   Norden, Lorraine E ^a   Griffin, A Jane ^a   Barnes, Margaret A ^c   Little, John A ^d  

^a CHASE FARM HOSPITAL   (United Kingdom)

^b Enfield Primary Care Trust   (United Kingdom)

^c Eagle House Surgery   (United Kingdom)

^d QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

Affinity chromatography; Equilibrium dialysis; Fluoroimmunoassay; Hyperthyroidism; Immunoabsorption; Polyethylene glycol; Rheumatoid arthritis; Thyroid stimulating hormone

Indexed keywords

GLOBULIN; RHEUMATOID FACTOR; THYROTROPIN; THYROXINE;

AGED; ARTICLE; CLINICAL TRIAL; EQUILIBRIUM DIALYSIS; FEMALE; FREE LIOTHYRONINE INDEX; FREE THYROXINE INDEX; HUMAN; HYPERTHYROIDISM; IMMUNOASSAY; IMMUNORADIOMETRIC ASSAY; LABORATORY DIAGNOSIS; MAJOR CLINICAL STUDY; PROSPECTIVE STUDY; RHEUMATOID ARTHRITIS; THYROTROPIN BLOOD LEVEL; THYROXINE BLOOD LEVEL;

EID: 0030947476     PISSN: 00099147     EISSN: None     Source Type: Journal    
DOI: 10.1093/clinchem/43.6.957     Document Type: Article

References (13)

1. Keffer JH. Preanalytical considerations in testing thyroid function. Clin Chem 1996;42:125-34.
2. Lazarus JH, John R, Hall R. Thyroid disorders. In: Bouloux P-MG, Rees LH, eds. Diagnostic tests in endocrinology and diabetes. London: Chapman and Hall, 1994:39-66.
3. Rad TM, Duffy J, McKenna TJ. Multiple spuriously abnormal thyroid function indices due to heterophilic antibodies. Clin Endocrinol 1994;41:391-5.
4. Nelson JC, Wilcox RB. Analytical performance of free and total thyroxine assays. Clin Chem 1996;42:146-54.
5. Liewendahl K, Melamies L, Helenius T, Karonen SL, Liljestrom E, Valimaki M. Automated and manual serum free thyroxine assays evaluated with equilibrium dialysis. Scand J Clin Lab Invest 1994;54:347-51.
6. 4 assay. J Clin Pathol 1994;47:181-2.
7. Tokmakjian S, Haines M, Edmonds M. Free thyroxine measured by the Ciba Corning ACS-180 on samples from patients with familial dysalbuminemic hyperthyroxinemia [Letter]. Clin Chem 1993;39: 1748-9.
8. 4 [Letter]. Clin Chem 1995;41:633-4.
9. Martin-du-Pan RC, Horak M, Bischof P. Clinical significance of invisible or partially visible luteinizing hormone. Hum Reprod 1994;9:1987-90.
10. Hamako J, Ozeki Y, Matsui T, Yamamoto Y, Inoue T, Yukitake J, Titani K. Binding of human IgM from a rheumatoid factor to IgG of 12 animal species. Comp Biochem Physiol 1995;112B:683-8.
11. Koopman WJ, Schrohenloher RE. In: Utsinger PD, Zvaifler NJ, Ehrlich GE, eds. Rheumatoid arthritis. Philadelphia: JB Lippincott Co., 1985:217-41.
12. Shiroky JB, Cohen M, Ballachey M-L, Neville C. Thyroid dysfunction in rheumatoid arthritis: a controlled prospective survey. Ann Rheum Dis 1993;52:454-6.
13. Thomas MJ, Adebajo A, Chapel HM, Webley M. The use of rheumatoid factors in clinical practice. Postgrad Med J 1995;71: 674-7.